• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CMB

CAMBIUM BIO LIMITED

0.00% ! 26.5¢
Market Cap $4.844M  !

Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage... Cambium Bio Limited, formerly Regeneus Ltd, is an Australia-based clinical-stage regenerative medicine company focusing on the development of biologics for ophthalmology and tissue repair applications. Its technology, based on human platelet lysate, is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. Its lead product candidate, Elate Ocular, is being developed to address significant unmet medical needs in the treatment of dry eye disease. Elate Ocular is formulated from the processing of base human platelets sourced not from patients, but generally healthier younger eligible donors at U.S. blood collection centers. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications. It also manufactures and sells stem cell growth supplements, such as UltraGRO Advanced, UltraGRO Pure (xeno-free), and UltraGRO Pure GI (xeno-free, gamma irradiated).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CMB 12/07/25 2 843
12/07/25 Last post  xerxer Comments Created with Sketch.  2  Views Created with Sketch.  843 
CMB 30/06/25 0 211
30/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  211 
CMB 13/06/25 2 1.1K
13/06/25 Last post  nigelnz Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
CMB 23/05/25 0 223
23/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
CMB 22/05/25 0 225
22/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  225 
CMB 22/05/25 0 209
22/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  209 
CMB 21/05/25 0 242
21/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  242 
CMB 15/04/25 6 3.6K
15/04/25 Last post  xerxer Comments Created with Sketch.  6  Views Created with Sketch.  3.6K 

See All Discussions arrow Created with Sketch.

Timeline

Cambium Bio Clears FDA Regulatory Hurdles
11 Jul 09:10
 
Cambium Bio Receives Ethics Approvals
30 Jun 09:23
 
Change of Address
23 May 15:56
 
Initial Director's Interest Notice - Denese Marks
22 May 16:36
 
Final Director's Interest Notice - Barry Sechos
22 May 16:35
 
Board and Company Secretary Changes
21 May 12:32
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
26.5¢
Change
0.000(0.00%)
Mkt cap ! $4.844M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 25000 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 15838 2
View Market Depth
Last trade - 16.21pm 25/07/2025 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.